المؤلفون: Allix-Beguec, C, Arandjelovic, I, Bi, L, Beckert, P, Bonnet, M, Bradley, P, Cabibbe, AM, Cancino-Munoz, I, Caulfield, MJ, Chaiprasert, A, Cirillo, DM, Clifton, D, Comas, I, Crook, DW, De Filippo, MR, De Neeling, H, Diel, R, Drobniewski, FA, Faksri, K, Farhat, MR, Fleming, J, Fowler, P, Fowler, TA, Gao, Q, Gardy, J, Gascoyne-Binzi, D, Gibertoni-Cruz, A-L, Gil-Brusola, A, Golubchik, T, Gonzalo, X, Grandjean, L, He, G, Guthrie, JL, Hoosdally, S, Hunt, M, Iqbal, Z, Ismail, N, Johnston, J, Khanzada, FM, Khor, CC, Kohl, TA, Kong, C, Lipworth, S, Liu, Q, Maphalala, G, Martinez, E, Mathys, V, Merker, M, Miotto, P, Mistry, N, Moore, DAJ, Murray, M, Niemann, S, Ong, RT-H, Peto, TEA, Posey, JE, Prammananan, T, Pym, A, Rodrigues, C, Rodrigues, M, Rodwell, T, Rossolini, GM, Padilla, ES, Schito, M, Shen, X, Shendure, J, Sintchenko, V, Sloutsky, A, Smith, EG, Snyder, M, Soetaert, K, Starks, AM, Supply, P, Suriyapol, P, Tahseen, S, Tang, P, Teo, Y-Y, Thuong, TNT, Thwaites, G, Tortoli, E, Omar, S, Van Soolingen, D, Walker, AS, Walker, TM, Wilcox, M, Wilson, DJ, Wyllie, D, Yang, Y, Zhang, H, Zhao, Y, Zhu, B

المصدر: 1415 ; 1403

مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Medicine, General & Internal, General & Internal Medicine, RESISTANT TUBERCULOSIS, MULTIDRUG-RESISTANCE, XPERT MTB/RIF, TRANSMISSION, MUTATIONS, DIAGNOSIS, Antitubercular Agents, Drug Resistance, Bacterial, Ethambutol, Genome, Genotype, Humans, Isoniazid, Microbial Sensitivity Tests, Mutation, Mycobacterium tuberculosis, Phenotype, Pyrazinamide, Rifampin, Tuberculosis, Whole Genome Sequencing, CRyPTIC Consortium and the 100,000 Genomes Project, 11 Medical And Health Sciences

العلاقة: New England Journal of Medicine; http://hdl.handle.net/10044/1/64939Test; https://x.doi.org/10.1056/NEJMoa1800474Test

الإتاحة: https://doi.org/10.1056/NEJMoa1800474Test
http://hdl.handle.net/10044/1/64939Test

المؤلفون: Zumla, A, Maeurer, M, Chakaya, J, Hoelscher, M, Ntoumi, F, Rustomjee, R, Vilaplana, C, Yeboah-Manu, D, Rasolofo, V, Munderi, P, Singh, N, Aklillu, E, Padayatchi, N, Macete, E, Kapata, N, Mulenga, M, Kibiki, G, Mfinanga, S, Nyirenda, T, Mboko, L, Garcia-Basteiro, AL, Rakotosamimanana, N, Bates, M, Mwaba, P, Reither, K, Gagneux, S, Edwards, S, Mfinanga, E, Abdulla, S, Cardona, P-J, Russell, JBW, Gant, V, Noursadeghi, M, Elkington, P, Bonnet, M, Menendez, C, Dieye, TN, Diarra, B, Maiga, A, Aseffa, A, Parida, S, Wejse, C, Petersen, E, Kaleebu, P, Oliver, M, Craig, G, Corrah, T, Tientcheu, L, Antonio, M, McHugh, TD, Sheikh, A, Ippolito, G, Ramjee, G, Kaufmann, SHE, Churchyard, G, Steyn, AJC, Grobusch, MP, Sanne, I, Martinson, N, Mandansein, R, Wilkinson, RJ, Wallis, RS, Mayosi, B, Schito, M

المصدر: 1438 ; 1432

مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Immunology, Infectious Diseases, Microbiology, host-directed therapy, tuberculosis, treatment, multi-drug resistant tuberculosis, repurposed drugs, SUB-SAHARAN AFRICA, DEVELOPING-COUNTRIES, PULMONARY TUBERCULOSIS, ADJUNCT THERAPIES, MOXIFLOXACIN, REGIMENS, TRIALS, DRUGS, OPPORTUNITIES, PARTNERSHIPS, Antitubercular Agents, Combined Modality Therapy, Humans, Mycobacterium tuberculosis, Precision Medicine, Time Factors, Multidrug-Resistant, Host-Directed Therapies Network (HDT-NET) Consortium, 06 Biological Sciences, 11 Medical And Health Sciences

العلاقة: CLINICAL INFECTIOUS DISEASES; http://hdl.handle.net/10044/1/51747Test

الإتاحة: https://doi.org/10.1093/cid/civ631Test
http://hdl.handle.net/10044/1/51747Test